﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>34</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>02</Month>
        <DAY>26</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Comparison‍‍‍‍ of Efficacy of Topical Combination Solution of Salicylic Acid %2 and Erythromycin% 4 with Topical Solution of Erythromycin 4% Alone in Mild to Moderate Acne Vulgaris Treatment: A Double-Blinded Randomized Clinical Trial</ArticleTitle>
    <FirstPage>67</FirstPage>
    <LastPage>71</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Farideh Golfroushan</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Hamideh Azimi</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Ebrahim Tayefeh Hosein Ali</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>02</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: Acne Vulgaris is one of the most common skin disorders involving pilosebaceous units resulting in hyperkeratinization, sebum production and inflammation. It involves 85% of individuals aging 12 to 24 years a physiologic phenomenon in this age group. Materials and Methods: 50 patients with mild to moderate acne vulgaris were subdivided in two equal groups, groups and it is (group A &amp; group B each other with 25 patients) in a double-blinded trial; the therapeutic effect of topical erythromycin solution 4% was with combination of erythromycin 4% and salicylic acid 2%. Results: In this recruitees 14 (28%) patients were male and 36 (72%) were female. The mean age of patients was 20.3±3.2 15 to 29 years. The mean TLC after treatment in erythromycin group was 21.6±6.6 while in combination therapy group it was 9.8±5 (P=0.0001). 16% of patients in erythromycin group and 76% of patients in erythromycin plus salicylic acid experienced complications including irritation, erythema and xerosis which was significantly different (P=0.0001). Conclusion: The efficacy therapy with combination of erythromycin 4% and salicylic 2% is more than erythromycin 4% alone in the treatment of facial acne vulgaris, but side effects were more prominent in combination therapy.</Abstract>
  </Article>
</ArticleSet>